REBIF 22 micrograms, solution for injection in a pre-filled syringe 12 syringes of 0.5 ml
Active ingredients: Interferon beta-1a
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection12 syringes of 0.5 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- REBIF 22 microgrammes, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 12 seringue(s) préremplie(s) en verre de 0,5 ml avec aiguille(s) acier
- Marketing authorisation holder
- MERCK SERONO EUROPE (ROYAUME-UNI)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Jan 1999
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62090595CIP73474170CIP133400934741708Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| INTERFÉRON BÊTA-1Asolution | 22 microgrammes · une seringue pré-remplie | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.